Search

10 results on this page

Shiyao's AI Drug Bet Needs Real Products

Shiyao's AI Drug Bet Needs Real Products

石藥創新上半年營收與淨利大幅增長,主要由巨石生物與AstraZeneca合作取得的4.2億美元首付款帶動,而非已上市藥品銷售。這項合作凸顯其AI多肽發現平台與LiquidGel長效遞送技術的價值,但公司仍需依靠ADC等候選藥物上市,才能從出售管線轉向銷售產品。

Scale Agentic AI Without Lock-In

Scale Agentic AI Without Lock-In

AWS outlines enterprise patterns for operating many agentic AI systems across diverse frameworks, models, and providers. The guidance focuses on preserving flexibility and enabling multi-agent systems to scale together without vendor lock-in.

AWS Machine Learning BlogOfficial10h ago#agentic-ai#multi-agent#vendor-lock-in
Page 1